Work

A phase II study of continuous infusion recombinant human granulocyte- macrophage colony-stimulating factor as an adjunct to autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma in first remission

Year: 1994

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v83.9.2707.2707

Authors: SJ O'Day, SN Rabinowe, D Neuberg, AS Freedman, RJ Soiffer, NA Spector, MJ Robertson, K Anderson, M Whelan, K Pesek

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: PROGRAM OF STUDIES ON THE BIOLOGY AND TREATMENT OF HUMAN, G2307546518, G2541397611, G6771804199, Dana-Farber/Harvard Cancer Center

OpenAlex ID: W2372328744

FWCI: 1.296

Cites: 37

Cited by: 16

Related to: 10